PPBT

Purple Biotech Ltd. NASDAQ Listed Nov 20, 2015

Healthcare ·Biotechnology ·IL · purple-biotech.com

$3.99

Mkt Cap $550,955

52w Low $3.60 1.5% of range 52w High $29.00

50d MA $4.29 200d MA $8.50

P/E (TTM) 0.0x

EV/EBITDA 1.2x

P/B 0.0x

Debt/Equity 0.0x

ROE —

P/FCF -0.0x

RSI (14) —

ATR (14) —

Beta -0.70

50d MA $4.29

200d MA $8.50

Avg Volume 14.4K

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 1b/2 clinical trials for the treatment of non-small cell lung cancer and pancreatic cancer; and NT219, a small molecule that targets insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment of recurrent and/or metastatic solid tumors and squamous cell carcinoma of the head and neck cancer. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. The company is headquartered in Rehovot, Israel.

SIC Code

2834

CIK (SEC)

1614744

Phone

972 3 933 3121

4 Oppenheimer Street · Rehovot, L3 7670104 · IL

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 13, 2026	AMC	-3.40	-19.85	-483.8%	4.10	-0.7%	-0.2%	-2.4%	-4.5%	-0.5%	+5.0%	—
Nov 14, 2025	AMC	-0.26	-0.29	-11.5%	7.18	-1.5%	+0.3%	+11.2%	-4.6%	-0.3%	+0.5%	—
Aug 6, 2025	AMC	-0.21	-0.40	-90.5%	21.50	-0.9%	+0.0%	-0.9%	+3.3%	+2.3%	-0.9%	—
May 21, 2025	AMC	—	-0.17	—	23.70	+3.8%	+5.1%	-3.7%	-2.2%	+4.5%	-2.4%	—
Mar 10, 2025	AMC	-0.22	-0.26	-18.2%	27.15	+1.7%	-2.4%	+3.0%	-1.1%	+0.9%	+2.8%	—
Nov 15, 2024	AMC	-1.20	-1.37	-14.2%	25.05	+0.6%	+1.8%	+2.7%	-5.7%	+2.8%	-13.8%	—
Aug 16, 2024	AMC	-0.16	-1.60	-900.0%	73.44	+0.7%	+0.2%	+14.2%	-5.3%	-4.5%	+5.2%	—
May 21, 2024	AMC	-3.00	-3.00	+0.0%	120.00	+3.5%	+13.3%	+17.6%	-6.9%	+5.4%	-0.6%	—
Mar 5, 2024	AMC	-3.40	-6.40	-88.2%	160.00	+3.8%	+1.9%	+6.2%	-5.2%	-6.5%	-4.1%	—
Nov 21, 2023	AMC	-4.40	-4.20	+4.5%	198.50	+0.8%	+2.8%	+1.0%	-4.9%	+1.0%	+9.1%	—
Aug 22, 2023	AMC	-5.00	-4.60	+8.0%	246.00	-1.6%	-2.4%	-2.5%	+0.0%	-0.4%	+3.0%	—
May 16, 2023	AMC	-7.00	-4.20	+40.0%	366.00	+1.6%	+3.0%	-1.3%	+3.2%	+2.1%	-0.5%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 13	HC Wainwright & Co.	Maintains	Buy → Buy	—	$3.84	$3.83	-0.3%	+6.8%	-0.2%	-2.4%	-4.5%	-0.5%
Nov 15	HC Wainwright & Co.	Maintains	Buy → Buy	—	$25.20	$25.10	-0.4%	-0.6%	+1.8%	+2.7%	-5.7%	+2.8%
Sep 20	HC Wainwright & Co.	Maintains	Buy → Buy	—	$69.80	$70.30	+0.7%	-1.3%	-5.8%	-7.5%	-5.9%	-8.4%
Aug 19	HC Wainwright & Co.	Maintains	Buy → Buy	—	$73.44	$73.98	+0.7%	+0.2%	+14.2%	-5.3%	-4.5%	+5.2%
Jul 11	HC Wainwright & Co.	Maintains	Buy → Buy	—	$82.56	$81.30	-1.5%	-7.8%	+4.9%	-4.8%	-0.4%	+1.0%
May 21	HC Wainwright & Co.	Maintains	Buy → Buy	—	$112.63	$116.60	+3.5%	+6.5%	+13.3%	+17.6%	-6.9%	+5.4%
Apr 26	HC Wainwright & Co.	Maintains	Buy → Buy	—	$103.20	$98.00	-5.0%	-5.0%	+4.1%	+1.7%	+0.8%	+3.4%
Mar 7	Chardan Capital	Maintains	Buy → Buy	—	$163.00	$167.50	+2.8%	+6.2%	-5.2%	-6.5%	-4.1%	-3.4%
Mar 5	HC Wainwright & Co.	Maintains	Buy → Buy	—	$166.00	$158.40	-4.6%	-3.6%	+1.9%	+6.2%	-5.2%	-6.5%
Feb 27	HC Wainwright & Co.	Maintains	Buy → Buy	—	$142.54	$146.80	+3.0%	-5.9%	+4.3%	+17.4%	+11.8%	-9.6%
Nov 21	HC Wainwright & Co.	Maintains	Buy → Buy	—	$200.00	$193.82	-3.1%	-0.8%	+2.8%	+1.0%	-4.9%	+1.0%
Aug 31	HC Wainwright & Co.	Maintains	Buy → Buy	—	$240.00	$244.00	+1.7%	+0.8%	+7.4%	-3.1%	-3.2%	-2.5%
Aug 30	HC Wainwright & Co.	Maintains	Buy → Buy	—	$240.00	$236.00	-1.7%	+0.0%	+0.8%	+7.4%	-3.1%	-3.2%
May 17	HC Wainwright & Co.	Maintains	Buy → Buy	—	$366.00	$372.00	+1.6%	+3.0%	-1.3%	+3.2%	+2.1%	-0.5%
May 17	Chardan Capital	Maintains	Buy → Buy	—	$366.00	$372.00	+1.6%	+3.0%	-1.3%	+3.2%	+2.1%	-0.5%
Feb 9	HC Wainwright & Co.	Maintains	Buy → Buy	—	$369.00	$360.00	-2.4%	+1.9%	-1.6%	+1.1%	+6.7%	+12.8%
Feb 9	Chardan Capital	Maintains	Buy → Buy	—	$369.00	$360.00	-2.4%	+1.9%	-1.6%	+1.1%	+6.7%	+12.8%
Oct 17	HC Wainwright & Co.	Maintains	Buy → Buy	—	$396.00	$430.00	+8.6%	-1.5%	+3.8%	+0.7%	+1.0%	+2.4%
Sep 8	Chardan Capital	Maintains	Buy → Buy	—	$454.00	$500.00	+10.1%	-5.3%	+0.0%	+6.0%	-3.1%	-0.5%

Data updated apr 26, 2026 8:27pm · Source: massive.com